AstraZeneca Cancer Drug MEDI4736 Data Supports further Trials

June 4, 2014 4:33 AM

1 0

On Tuesday, Britain’s AstraZeneca said that MEDI4736 experimental cancer drug clinical trials were supporting the immunotherapy cancer treatment and has opened new gates of testing.

In Chicago, AstraZeneca presented its data at the annual American Society of Clinical Oncology (ASCO) meeting.

Also read: National Cancer Institute Says Researchers Didn’t Quickly Tell FDA After Two Deaths in a Lymphoma Study

Read more

To category page